Antioxidant hybrid compounds: A promising therapeutic intervention in oxidative stress induced diseases

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 2, 2013, Pages 280-297

  Tailor, Navin ^a   Sharma, Manu ^a  

^a JAYPEE UNIVERSITY OF INFORMATION TECHNOLOGY   (India)

Author keywords

Antioxidant hybrid compound; Reactive oxygen species; Structure activity relationship

Indexed keywords

1, 2 DITHIOLONE; ALPHA BETA UNSATURATED CARBONYL; ALPHA TOCOPHEROL; ANTIOXIDANT; ANTIOXIDANT HYBRID COMPOUND; CHALCONE; CINNAMIC ACID; ESTRADIOL; ESTROGEN RECEPTOR; FLAVONOID; HYPOXIA INDUCIBLE FACTOR 1; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; NUCLEOSIDE ANALOG; PACLITAXEL; PHOSPHOLIPASE A2; PROCAINAMIDE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN P53; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN I; TAMOXIFEN; THIOCTIC ACID; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLEEDING; BREAST CANCER; CHILL; COUGHING; DIZZINESS; DYSPHAGIA; DYSPNEA; EXHAUSTION; FEMALE INFERTILITY; FEVER; FLUSHING; HEART ARRHYTHMIA; HEART PROTECTION; HEPATITIS C VIRUS; HUMAN; INFLAMMATION; INJECTION SITE SWELLING; NEUROPROTECTION; NONHUMAN; OVARY DISEASE; OXIDATIVE STRESS; PAIN; PHASE 1 CLINICAL TRIAL (TOPIC); RADIATION PROTECTION; RASH; SIDE EFFECT; SIGNAL TRANSDUCTION; SORE THROAT; STRUCTURE ACTIVITY RELATION; UNSPECIFIED SIDE EFFECT;

EID: 84876820944     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955713804805175     Document Type: Article

References (212)

1. Simonian, N.A., Coyle, J.T. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol., 1996, 36, 83-106.
2. Inoue, M.; Sato, E.F.; Nishikawa, M.; Park, A.M.; Kira, Y.; Imada, I.; Utsumi K. Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr. Med. Chem., 2003, 10, 2495-2505.
3. Li, C.; Jackson, R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell. Physiol., 2002, 282, C227-C241.
4. Conner, E.M.; Grisham, M.B. Inflammation, free radicals, and antioxidants. Nutrition, 1996, 12, 274-277.
5. Gupta, M.; Dobashi, K.; Greene, E.L.; Orak, J.K.; Singh, I. Studies on hepatic injury and antioxidant enzyme activities in rat subcellular organelles following in vivo ischemia and reperfusion. Mol. Cell. Biochem., 1997, 176, 337-347.
6. Morel, Y.; Barouki, R. Repression of gene expression by oxidative stress. Biochem. J., 1999, 342, 481-496.
7. Valko, M.; Morris, H.; Cronin, M.T. Metals, toxicity and oxidative stress. Curr. Med. Chem., 2005, 12, 1161-1208.
8. Leonard, S.S.; Harris, G.K.; Shi, X. Metal-induced oxidative stress and signal transduction. Free Radic. Biol. Med., 2004, 37, 1921-1942.
9. Halliwell, B.; Guteridge, J.M. Role of free-radicals and catalytic metal-ions in human disease-an overview. Methods Enzymol., 1990, 186, 1-85.
10. Mates, J.M.; Perez-Gomez, C.; Nunez, De C.I. Antioxidant enzymes and human diseases. Clin. Biochem., 1999, 32, 595-603.
11. McCall, M.R.; Frei, B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Rad. Biol. Med., 1999, 26, 1034-1053.
12. Marnett, L.J. Oxyradicals and DNA damage. Carcinogenesis, 2000, 21, 361-370.
13. Cooke, M.S.; Evans, M.D.; Dizdaroglu, M.; Lunec, J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J., 2003, 17, 1195-1214.
14. Reuter, S.; Gupta, S.C.; Chaturvedi, M.M.; Aggarwal, B.B. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med., 2010, 49, 1603-1616.
15. Welch, K.D.; van Eden, M.E.; Aust, S.D. Modification of ferritin during iron loading. Free Radic. Biol. Med., 2001, 31, 999-1006.
16. Stadtman, E.R. Protein oxidation in aging and age-related diseases. Ann. N. Y. Acad. Sci., 2001, 928, 22-38.
17. Levine, R.L.; Stadtman, E.R. Oxidative modification of proteins during aging. Exp. Gerontol., 2001, 36, 1495-1502.
18. Thannickal, V.J.; Fanburg, B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol., 2000, 279, L1005-L1028.
19. Poli, G.; Leonarduzzi, G.; Biasi, F.; Chiarpotto, E. Oxidative stress and cell signaling. Curr. Med. Chem., 2004, 11, 1163-1182.
20. Zhao, J.; Miao, J.; Zhao, B.; Zhang, S. Upregulating of Fas, integrin beta4 and P53 and depressing of PC-PLC activity and ROS level in VEC apoptosis by safrole oxide. FEBS Lett., 2005, 579, 5809-5813.
21. Cheng, Y.; Zhao, Q.; Liu, X.; Araki, S.; Zhang, S.; Miao, J. Phosphatidylcholine-specific phospholipase C, p53 and ROS in the association of apoptosis and senescence in vascular endothelial cells. FEBS Lett., 2006, 580, 4911-4915.
22. Akiyama, N.; Nabemoto, M.; Hatori, Y.; Nakamura, H.; Hirabayashi, T.; Fujino, H.; Saito, T.; Murayama, T. Up-regulation of cytosolic phospholipase A2 alpha expression by N, N diethyldithiocarbamate in PC12 cells; involvement of reactive oxygen species and nitric oxide. Toxicol. Appl. Pharmacol., 2006, 215, 218-227.
23. Muralikrishna, A.R.; Hatcher, J.F. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med., 2006, 40, 376-387.
24. Tappia, P.S.; Dent, M.R.; Dalla, N.S. Oxidative stress and redox regulation of phospholipase D in myocardial disease. Free Radic. Biol. Med., 2006, 41, 349-361.
25. + channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation, 2006, 13, 615-632.
26. Thomas, M.P.; Chartrand, K.; Reynolds, A.; Vitvitsky, V.; Banerjee, R.; Gendelman, H.E. Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease. J. Neurochem., 2007, 100, 503-519.
27. 2+ uptake in apoptosis. Cell Calcium., 2006, 40, 553-560.
28. Nakamura, K.; Hori, T.; Sato, N.; Sugie, K.; Kawakami, T.; Yodoi, J. Redox regulation of a src family protein tyrosine kinase p56lck in T cells. Oncogene., 1993, 8, 3133-3139.
29. O'Hara, K.A.; Klei, L.R.; Barchowsky, A. Selective activation of Src family kinases and JNK by low levels of chromium (VI). Toxicol. Appl. Pharmacol., 2003, 190, 214-223.
30. Chang, L.; Karin, M. Mammalian MAP kinase signaling cascades. Nature, 2001, 410, 37-40.
31. Schmitz, M.L.; Bacher, S.; Droge, W. Molecular analysis of mitogen-activated protein kinase signaling pathways induced by reactive oxygen intermediates. Methods Enzymol., 2002, 352, 53-61.
32. Okuno, H.; Akahori, A.; Sato, H.; Xanthoudakis, S.; Curran, T.; Iba, H. Escape from redox regulation enhances the transforming activity of Fos. Oncogene, 1993, 8, 695-701.
33. Schreck, R.; Rieber, P.; Baeuerle, P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J., 1991, 10, 2247-2258.
34. Wilson, J.N.; Pierce, J.D.; Clancy, R.L. Reactive oxygen species in acute respiratory distress syndrome. Heart Lung, 2001, 30, 370-375.
35. Dugan, L.L.; Quick, K.L. Reactive oxygen species and aging: evolving questions. Sci. Aging. Knowledge Environ., 2005, 26, pe20.
36. Hensley, K.; Butterfield, D.A.; Hall, N.; Cole, P.; Subramaniam, R.; Mark, R.; Mattson, M. P.; Markesbery, W.R.; Harris, M.E.; Aksenov, M. Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease associated amyloid beta peptide. Ann. N. Y. Acad. Sci., 1996, 786, 120-134.
37. Multhaup, G.; Ruppert, T.; Schlicksupp, A.; Hesse, L.; Beher, D.; Masters, C.L.; Beyreuther, K. Reactive oxygen species and Alzheimer's disease. Biochem. Pharmacol., 1997, 54, 533-539.
38. Halliwell, B. Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br. J. Exp. Pathol., 1989, 70, 737-757.
39. Lau, A.T.; Wang, Y.; Chiu, J.F. Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. J. Cell. Biochem., 2008, 104, 657-667.
40. Renschler, M.F. The emerging role of reactive oxygen species in cancer therapy. Eur. J. Cancer, 2004, 40, 1934-1940.
41. Weinberg, F.; Chandel, N.S. Reactive oxygen species-dependent signaling regulates cancer. Cell. Mol. Life Sci., 2009, 66, 3663-3673.
42. Touyz, R.M. Reactive oxygen species and angiotensin II signaling in vascular cells-implications in cardiovascular disease. Braz. J. Med. Biol. Res., 2004, 37, 1263-1273.
43. Yoshizumi, M.; Tsuchiya, K.; Tamaki, T. Signal transduction of reactive oxygen species and mitogen-activated protein kinases in cardiovascular disease. J. Med. Invest., 2001, 48, 11-24.
44. Muhammad, S.; Bierhaus, A.; Schwaninger, M. Reactive oxygen species in diabetes- induced vascular damage, stroke, and Alzheimer's disease. J. Alzheimers Dis., 2009, 16, 775-785.
45. Di Virgilio, F. New pathways for reactive oxygen species generation in inflammation and potential novel pharmacological targets. Curr. Pharm. Des., 2004, 10, 1647-1652.
46. Moulton, P.J. Inflammatory joint disease: the role of cytokines, cyclooxygenases and reactive oxygen species. Br. J. Biomed. Sci., 1996, 53, 317-324.
47. Bolanos, J.P.; Moro, M.A.; Lizasoain, I.; Almeida, A. Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: therapeutic implications. Adv. Drug Deliv.Rev., 2009, 61, 1299-1315.
48. Atabek, M.E.; Vatansev, H.; Erkul, I. Oxidative stress in childhood obesity. J. Pediatr. Endocrinol. Metab., 2004, 17, 1063-1068.
49. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest., 2004, 114, 1752-1761.
50. Tabner, B.J.; Turnbull, S.; El-Agnaf, O.; Allsop, D. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Curr. Top. Med. Chem., 2001, 1, 507-517.
51. Kamp, D.W.; Graceffa, P.; Pryor, W.A.; Weitzman, S.A. The role of free radicals in asbestos-induced diseases. Free Radic. Biol. Med., 1992, 12, 293-315.
52. Gelderman, K.A.; Hultqvist, M.; Olsson, L.M.; Bauer, K.; Pizzolla, A.; Olofsson, P.; Holmdahl, R. Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies. Antioxid. Redox Signal., 2007, 9, 1541-1567.
53. Haurani, M.J.; Pagano, P.J. Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease? Cardiovasc. Res., 2007, 75, 679-689.
54. Jeremy, J.Y.; Shukla, N.; Muzaffar, S.; Handley, A.; Angelini, G.D. Reactive oxygen species, vascular disease and cardiovascular surgery. Curr. Vasc. Pharmacol., 2004, 2, 229-236.
55. Garcia, A.A.; Grande B.C.; Gandara J.S. Development of a rapid method based on solid-phase extraction and liquid chromatography with ultraviolet absorbance detection for the determination of polyphenols in alcohol-free beers. J. Chromatogr. A., 2004, 1054, 175-80.
56. Perez-Lamela, C; Garcia-Falcon, M.S.; Simal-Gandara, J.; Orriols-Fernandez, I. Influence of grape variety, vine system and enological treatments on the colour stability of young red wines. Food Chem., 2007, 101, 601-606.
57. Alen-Ruiz, F.; Perez-Gregorio, M.R.; Martinez-Carballo, E.; Garcia-Falcon, M.S.; Simal-Gandara, J. Influence of polyphenols on colour and antioxidant value in plant foods. Electronic Journal of Environmental, Agricultural and Food Chemistry, 2008, 7, 3171-3176.
58. Rodrigues, A.S.; Perez-Gregorio, M.R.; Garcia-Falcón, M.S.; Simal-Gandara, J. Effect of curing and cooking on flavonols and anthocyanins in traditional varieties of onion bulbs. Food Res. Int., 2009, 42, 1331-1336.
59. Rodrigues, A.S.; Perez-Gregorio, M.R.; Garcia-Falcon, M.S.; Simal-Gandara, J.; Almeida, D.P.F. Effect of post-harvest practices on flavonoid content of red and white onion cultivars. Food Control, 2010, 21, 878-884.
60. Perez-Gregorio, R.M.; Garcia-Falcon, M.S.; Simal-Gandara, J.; Rodrigues, A.S.; Almeida, D.P.F. Identification and quantification of flavonoids in traditional cultivars of red and white onions at harvest. J. Food Comp. Anal., 2010, 23, 592-598.
61. Perez-Gregorio, M.R.; Regueiro, J.; Gonzalez-Barreiro, C; Rial-Otero, R.; Simal-Gandara, J. Changes in antioxidant flavonoids during freeze-drying of red onions and subsequent storage. Food Control, 2011, 22, 1108-1113.
62. Perez-Gregorio, M.R.; Gonzalez-Barreiro, C; Rial-Otero, R.; Simal-Gandara, J. Comparison of sanitizing technologies on the quality appearance and antioxidant levels in onion slices. Food Control, 2011, 22, 2052-2058.
63. Rodrigues, A.S.; Perez-Gregorio, M.R.; Garcia-Falcon, M.S. Simal-Gandara, J.; Almeida, D.P.F. Effect of meteorological conditions on antioxidant flavonoids in Portuguese cultivars of white and red onions. Food Chem., 2011, 124, 303-308.
64. Perez-Gregorio, M.R.; Garcia-Falcon, M.S.; Simal-Gandara, J. Flavonoids changes in fresh-cut onions during storage in different packaging systems. Food Chem., 2011, 124, 652-658.
65. Perez-Gregorio, M.R.; Regueiro, J.; Alonso-Gonzalez, E.; Pastrana-Castro L.M.; Simal-Gandara J. Influence of alcoholic fermentation process on antioxidant activity and phenolic levels from mulberries (Morus nigra L.). LWT - Food Sci. Tech., 2011, 44, 1793-1801.
66. Figueiredo-Gonzalez, M.; Martinez-Carballo, E.; Cancho-Grande, B.; Santiago, J.L.; Martínez, M.C.; Simal-Gandara, J. Pattern recognition of three Vitis vinifera L. red grapes varieties based on anthocyanin and flavonol profiles, with correlations between their biosynthesis pathways. Food Chem., 2012, 130, 9-19.
67. Leonarduzzi, G.; Sottero, B.; Poli, G. Targeting tissue oxidative damage by means of cell signaling modulators: the antioxidant concept revisited. Pharmacol. Ther., 2010, 128, 336-74.
68. Chandra, V.; Jasti, J.; Kaur, P.; Betzel, Ch.; Srinivasan, A.; Singh, T.P. First structural evidence of a specific inhibition of phospholipase A2 by a-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and a-tocopherol at 1.8 Å resolution. J. Mol. Biol., 2002, 320, 215-222.
69. Zingg J.M. Modulation of signal transduction by vitamin E. Mol. Aspects. Med., 2007, 28, 481-506.
70. Ricciarelli, R.; Tasinato, A.; Clement, S.; Ozer, N.K.; Boscoboinik, D.; Azzi, A. alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem. J., 1998, 334, 243-249.
71. Kempna, P.; Reiter, E.; Arock, M.; Azzi, A.; Zingg, J.M. Inhibition of HMC-1 mast cell proliferation by vitamin E: involvement of the protein kinase B pathway. J. Biol. Chem., 2004, 279, 50700-50709.
72. Linnewiel, K.; Ernst, H.; Carys-Veyrat, C; Ben-Dor, A.; Kampf, A.; Salman, H.; Danilenko, M.; Levy, J.; Sharoni, Y. Structure activity relationship of carotenoid derivatives in activation of the electrophile/antioxidant response element transcription system. Free Radic. Biol. Med., 2009, 47, 659-667.
73. Ochoa, W.F.; Torrecillas, A.; Fita, I.; Verdaquer, N.; Corbalan-Garcia, S.; Gomez-Fernandez, J.C. Retinoic acid binds to the C2-domain of protein kinase C (alpha). Biochemistry, 2003, 42, 8774-8779.
74. Kambhampati, S.; Li, Y.; Verma, A.; Sassano, A.; Majchrzak, B.; Deb D.K., Parmar, S.; Giafis, N.; Kalvakolanu, D.V.; Rahman A.; Uddin, S.; Minucci, S.; Tallman, M.S.; Fish, E.N.; Platanias, L.C. Activation of protein kinase C delta by all-trans-retinoic acid. J. Biol.Chem., 2003, 278, 32544-32551.
75. Vissers, M.C.; Gunningham, S.P.; Morrison, M.J.; Dachs, G.U.; Currie, M.J. Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate. Free Radic. Biol. Med., 2007, 42, 765-772.
76. Mahmmoud, Y.A. Modulation of protein kinase C by curcumin; inhibition and activation switched by calcium ions. Br. J. Pharmacol., 2007, 150, 200-208.
77. Conboy, L.; Foley, A.G.; O'Boyle, N.M.; Lawlor, M.; Gallagher, H.C.; Murphy, K.J.; Regan, C.M. Curcumin-induced degradation of PKC delta is associated with enhanced dentate NCAM PSA expression and spatial learning in adult and aged Wistar rats. Biochem. Pharmacol. 2009, 77, 1254-1265.
78. Hussain, A.R.; Ahmed, M.; Al-Jomah, N.A.; Khan, A.S.; Manogaran, P.; Sultana, M.; Abubakar, J.; Platanias, L.C.; Al-Kuraya, K.S.; Uddin, S. Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol. Cancer Ther., 2008, 7, 3318-3329.
79. Milacic, V.; Banerjee, S.; Landis-Piwowar, K.R.; Sarkar, F.H.; Majumdar, A.P.N; Dou, Q.P. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Res., 2008, 68, 7283-7292.
80. Hahm, E.R.; Cheon, G.; Lee, J.; Kim, B.; Park, C.; Yang, C.H. New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex. Cancer Lett., 2002, 184, 89-96.
81. Yu, R.; Hebbar, V.; Kim, D.W.; Mandlekar, S.; Pezzuto, J.M.; Kong, A.N. Resveratrol inhibits phorbol ester and UV-induced activator protein1 activation by intereferring with mitogen-activated protein kinase pathways. Mol. Pharmacol., 2001, 60, 217-22.
82. Hauptmann, N.; Grimsby, J.; Shih, J.C.; Cadenas, E. The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA. Arch. Biochem. Biophys., 1996, 335, 295-304.
83. Shakibaei, M.; Csaki, C.; Nebrich, S.; Mobasheri, A. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem. Pharmacol., 2008, 76, 1426-1439.
84. Yang, S.; Meyskens, F.L. Jr. Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma. Mol. Pharmacol., 2005, 67, 298-308.
85. Nishikawa, H.; Wakano, K.; Kitani, S. Inhibition of NADPH oxidase subunits translocation by tea catechin EGCG in mast cell. Biochem. Biophys. Res. Commun., 2007, 362, 504-509.
86. Teillet, F.; Boumendjel, A.; Boutonnat, J.; Ronot, X. Flavonoids as RTK inhibitors and potential anticancer agents. Med. Res. Rev., 2008, 28, 715-745.
87. Labbe, D.; Provençal, M.; Lamy, S.; Boivin, D.; Gingras, D.; Beliveau, R. The flavonols quercetin, kaempferol, and myricetin inhibit hepatocyte growth factorinduced medulloblastoma cell migration. J. Nutr., 2009, 139, 646-652.
88. Walker, E.H.; Pacold, M.E.; Perisic, O.; Stephens, L.; Hawkins, P.T.; Wymann, M.P.; Williams, R.L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurospirin. Mol. Cell., 2000, 6, 909-919.
89. Min, Y.D.; Choi, C.H.; Bark, H.; Son, H.Y.; Park, H.H.; Lee, S.; Park, J.W.; Park, E.K.; Shin, H.I.; Kim S.H. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm. Res., 2007, 56, 210-215.
90. Banerjee, S.; Li, Y.; Wang, Z.; Sarkar, F.H. Multi-target therapy of cancer by genistein. Cancer Lett., 2008, 269, 226-242.
91. Crespo, I.; Garcia-Mediavilla, M.V.; Gutierrez, B.; Sanchez-Campos, S.; Tunon, M.J.; Gonzalez-Gallego, J. A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells. Br. J. Nutr., 2008, 100, 968-976.
92. Chu, F.; Ward, N.E.; O'Brian, C.A. Potent inactivation of representative members of each PKC isozyme subfamily and PKD via S-thiolation by the tumorpromotion/progression antagonist glutathione but not by its precursor cysteine. Carcinogenesis, 2001, 22, 1221-1229.
93. Cross, J.V.; Templeton, DJ. Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain. Biochem. J., 2004, 381, 675-683.
94. Reynaert, N.L.; van der Vliet, A.; Guala, A.S.; McGovern, T.; Hristova, M.; Pantano, C. Heintz, N.H.; Heim, J.; Ho, Y.S.; Matthews, D.E.; Wouters, E.F.; Janssen-Heininger, Y.M. Dynamic redox control of NF-kappaB through glutaredoxin-regulated S glutathionylation of inhibitory kappaB kinase beta. Proc. Natl Acad. Sci. U.S.A., 2006, 103, 13086-13091.
95. Qanungo, S.; Starke, D.W.; Pai, H.V.; Mieyal, J.J.; Nieminen, A.L. Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFicB. J. Biol. Chem., 2007, 282, 18427-18436.
96. Velu, C.S.; Niture, S.K; Doneanu, C.E.; Pattabiraman, N. Srivenugopal, K.S. Human p53 is inhibited by glutathionylation of cysteine present in the proximal DNA-binding domain during oxidative stress. Biochemistry, 2007, 46, 7765-7780.
97. Balogun, E.; Hoque, M.; Gong, P.; Killeen, E.; Green, C.J.; Foresti, R.; Alam, J.; Motterlini, R. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem. J., 2003, 371, 887-895.
98. Kang, E.S.; Woo, I.S.; Kim, H.J.; Eun, S.Y.; Paek, K.S.; Kim, H.J.; Chang, K.C.; Lee, J.H.; Lee, H.T.; Kim, J.H.; Nishinaka, T.; Yabe-Nishimura, C; Seo, H.G. Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3-kinase/Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage. Free. Radic. Biol. Med., 2007, 43, 535-545.
99. Farombi, E.O.; Shrotriya, S.; Na, H.K; Kim, S.H.; Surh, YJ. Curcumin attenuates dimethyl nitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem. Toxicol, 2008, 46, 1279-1287.
100. Yang, C; Zhang, X.; Fan, H.; Liu, Y. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res., 2009, 1282, 133-141.
101. Kim, A.N.; Jeon, W.K.; Lee, J.J.; Kim, B.C. Up-regulation of heme oxygenase-1 expression through CaMKII-ERK1/2-Nrf2 signaling mediates the anti-inflammatory effect of bisdemethoxycurcumin in LPS-stimulated macrophages. Free Radic. Biol. Med., 2010, 49, 323-331.
102. Pandey, M.K; Kumar, S.; Thimmulappa, R.K; Parmar, V.S.; Biswal, S.; Watterson, A.C. Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells. Eur. J. Pharm. Sci., 2011, 43, 16-24.
103. Kweon, M.H.; In Park, Y.; Sung, H.C.; Mukhtar, H. The novel antioxidant 3-O-caffeoyl-1-methylquinic acid induces Nrf2-dependent phase II detoxifying genes and alters intracellular glutathione redox. Free Radic. Biol. Med., 2006, 40, 1349-1361.
104. Lee, Y.; Shin, D.H.; Kim, J.H.; Hong, S.; Choi, D.; Kim, YJ.; Kwak, M.K; Jung, Y. Caffeic acid phenethyl ester-mediated Nrf2 activation and IkB kinase inhibition are involved in NFkB inhibitory effect: Structural analysis for NFkB inhibition. Eur. J. Pharmacol, 2010, 643, 21-28.
105. Wang, X.; Stavchansky, S.; Kerwin, S.M.; Bowman, P.D. Structure-activity relationships in the cytoprotective effect of caffeic acid phenethyl ester (CAPE) and fluorinated derivatives: Effects on heme oxygenase-1 induction and antioxidant activities. Eur. J. Pharmacol, 2010, 635, 16-22.
106. Cao, X.; Xiao, H.; Zhang, Y.; Zou, L.; Chu, Y.; Chu, X. 1, 5-Dicaffeoylquinic acid-mediated glutathione synthesis through activation of Nrf2 protects against OGD/reperfusion-induced oxidative stress in astrocytes. Brain Res., 2010, 1347, 142-148.
107. Boettler, U; Sommerfeld, K; Volz, N; Pahlke, G.; Teller, N; Somoza, V.; Lang, R.; Hofmann, T.; Marko, D. Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression. J. Nutr. Biochem., 2011, 22, 426-440.
108. Kode, A.; Rajendrasozhan, S.; Caito, S.; Yang, S.R.; Megson, I.L.; Rahman, I. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am. J. Physiol. Lung Cell Mol Physiol, 2008, 294, L478-L488.
109. Fujita, H.; Shiosaka, M.; Ogino, T.; Okimura, Y.; Utsumi, T.; Sato, E.F.; Akagi, R.; Inoue, M.; Utsumi, K; Sasaki, J. Alpha-Lipoic acid suppresses 6-hydroxydopamine-induced ROS generation and apoptosis through the stimulation of glutathione synthesis but not by the expression of heme oxygenase-1. Brain Res., 2008, 1206, 1-12.
110. Huerta-Olvera, S.G.; Macias-Barragan, J.; Ramos-Márquez, M.E.; Armendariz-Borunda, J.; Diaz-Barriga, F.; Siller-Lopez, F. Alpha-lipoic acid regulates heme oxygenase gene expression and nuclear Nrf2 activation as a mechanism of protection against arsenic exposure in HepG2 cells. Environ. Toxicol. Pharmacol, 2010, 29, 144-149.
111. Huerta-Olvera, S.G.; Macias-Barragan, J.; Bueno-Topete, M.R.; Barriga-Martinez, F. D.; Luz-Madrigal, A.; Siller-Lopez, F. Lipoic acid regulates glutathione, heme oxygenase gene expression and nuclear Nrf2 activation as a mechanism of protection against arsenic exposure in HepG2 cells. Toxicology letters, 2008, 180, S35-S35.
112. Ogborne, R.M.; Rushworth, S.A.; O'Connell, MA. Epigallocatechin activates haem oxygenase-1 expression via protein kinase C8 and Nrf2. Biochem. Biophys. Res. Commun., 2008, 373, 584-588.
113. Na, H.K.; Kim, E.H.; Jung, J.H.; Lee, H.H.; Hyun, J.W.; Surh, YJ. (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Arch. Biochem. Biophys., 2008, 476, 171-177.
114. Na, H.K; Surh, YJ. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG Food Chem. Toxicol, 2008, 46, 1271-1278.
115. Sriram, N; Kalayarasan, S.; Sudhandiran, G. Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulm. Pharmacol. Ther., 2009, 22, 221-236.
116. Mehta, G.; Singh, V. Hybrid systems through natural product leads: An approach towards new molecular entities. Chem. Soc. Rev., 2002, 31, 324-334.
117. Suzuki, YJ.; Tsuchiya, M.; Packer, L. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic. Res. Commun., 1991, 15, 255-263.
118. Yan, L.J.; Traber, M.G.; Kobuchi, H.; Matsugo, S.; Tritschler, H.J.; Packer, L. Efficacy of hypochlorous acid scavengers in the prevention of protein carbonyl formation. Arch. Biochem. Biophys., 1996,327, 330-334.
119. Kagan, V.E.; Shvedova, A.; Serbinova, E.; Khan, S.; Swanson, C; Powell, R.; Packer, L. Dihydrolipoic acid - a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem. Pharmacol., 1992, 44, 1637-1649.
120. Packer, L.; Tritschler, H.J.; Wessel, K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic. Biol. Med., 1997, 22, 359-378.
121. Koufaki, M.; Kiziridi, C; Nikoloudaki F.; Alexis M.N. Design and synthesis of 1, 2-dithiolane derivatives and evaluation of their neuroprotective activity. Bioorg. Med.Chem. Lett., 2007, 17, 4223-4227.
122. Melagraki, G.; Afantitis, A.; Igglessi-Markopoulou, O.; Detsi, A.; Koufaki, M.; Kontogiorgis, C; Hadjipavlou-Litina, D.J. Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alphalipoic acid adducts. Eur. J. Med. Chem., 2009, 44, 3020-3026.
123. Woo, Y.J.; Lee, B.H.; Yeun, G.H.; Kim, H.J.; Ko, J.M.; Won, M.H.; Lee, B.H.; Park, J.H. Development of Selective Butyrylcholinesterase Inhibitors Using (R)-Lipoic Acid-Polyphenol Hybrid Molecules. Bull. Korean Chem. Soc, 2011, 32, 2997-3002.
124. Decker, M.; Kraus, B.; Heilmann, J. Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties. Bioorg. Med. Chem., 2008, 16, 4252-4261.
125. Koufaki, M.; Calogeropoulou, T.; Rekka, E.; Chryselis, M.; Papazafiri, P.; Gaitanaki, C; Makriyannis, A. Bifunctional Agents for Reperfusion Arrhythmias: Novel Hybrid Vitamin E/Class I Antiarrhythmics. Bioorg. Med. Chem., 2003, 11, 5209-5219.
126. Koufaki, M.; Detsi, A.; Theodorou, E.; Kiziridi, C; Calogeropoulou, T.; Vassilopoulos, A.; Kourounakis, A.P.; Rekka, E.; Kourounakis, P.N.; Gaitanaki, C; Papazafiri, P. Synthesis of chroman analogues of lipoic acid and evaluation of their activity against reperfusion arrhythmias. Bioorg. Med. Chem., 2004, 12, 4835-4841.
127. Altun, A.; Ugur-Altun, B. Melatonin: therapeutic and clinical utilization. Int. J. Clin. Pract., 2007, 61, 835-845.
128. Reiter, R.J.; Acuna-Castroviejo, D.; Tan, D.X.; Burkhardt, S. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann. N. Y. Acad. Sci., 2001, 939, 200-215.
129. Venkatachalam, S.R.; Salaskar, A.; Chattopadhyay, A.; Barik, A.; Mishra, B.; Gangabhagirathic, R.; Priyadarsin, K.I. Synthesis, pulse radiolysis, and in vitro radioprotection studies of melatoninolipoamide, a novel conjugate of melatonin and a-lipoic acid. Bioorg. Med. Chem., 2006, 14, 6414-6419.
130. Todeschini, A.R.; de Miranda, A.L.P.; da Silva, K.C.M.; Parrini, S.C; Barreiro, E.J. Synthesis and evaluation of analgesic, antiinflammatory and antiplatelet properties of new 2-pyridylarylhydrazone derivatives. Eur. J. Med. Chem., 1998, 33, 189-199.
131. Laneri, S.; Sacchia, A.; Gallitelli, M.; Arena, F.; Luraschi, E.; Abignente, E.; Filippelli, W.; Rossi, F. Research on heterocyclic compounds - Part XXXIX. 2-Methylimidazo[1,2-a]pyrimidine-3-carboxylic derivatives: Synthesis and antiinflammatory activity. Eur. J. Med. Chem., 1998, 33, 163-170.
132. Ozturk, G.; Erol, D.D.; Uzbay, T.; Aytemir, M.D. Synthesis of 4(1H)-pyridinone derivatives and investigation of analgesic and antiinflammatory activities. Farmaco, 2001, 56, 251-256.
133. Abignente, E.; Caprariis, P.de.; Rimoli, M.G.; Avallone, L.; Paloma, L.G.; Rossi, F.; Amico, M.D.; Calderaro, V.; Parrillo, C. Research on heterocyclics. XXXI. Stnthesis and anti-inflammatory activity of 2-arylimidazo[1,2-a]pyrazine-3-carboxlic acids. Eur. J. Med. Chem., 1993, 28, 337-346.
134. Rani, P.; Srivastava, V.K; Kumar, A. Synthesis and antiinflammatory activity of heterocyclic indole derivatives. Eur. J. Med. Chem., 2004, 39, 449-452.
135. Bezerra, N.M.; De Oliveira, S.P.; Srivastava, R.M.; Da Silva, J.R. Synthesis of 3-aryl-5-decapentyl-1,2,4-oxadiazoles possessing antiinflammatory and antitumor properties. Farmaco, 2005, 60, 955-960.
136. Detsi, A.; Bouloumbasi, D.; Prousis, K.C.; Koufaki, M.; Athanasellis, G.; Melagraki, G.; Afantitis, A.; Iqqlessi-Markopoulou, O.; Kontogiorgis, C; Hadjipavlou-Litina, D.J. Design and synthesis of novel quinolinone-3-aminoamides and their a-lipoic acid adducts as antioxidant and Anti-inflammatory Agents. J. Med. Chem., 2007, 50, 2450-2458.
137. Melagraki, G.; Afantitis, A.; Igglessi-Markopoulou, O.; Detsi, A.; Koufaki, M.; Kontogiorgis, C; Hadjipavlou-Litina, D.J. Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts. Eur. J. Med. Chem., 2009, 44, 3020-3026.
138. Opletalova, V. Chalcones and their heterocyclic analogs as potential therapeutic agents in bacterial diseases. Ceska. Slov. Farm., 2000, 49, 278-284.
139. Lee, T.T; Kashiwada, Y.; Huang, L.; Snider, J.; Cosentino, M.; Lee, K.H. Suksdorfin: an anti-HIV principle from Lomatium suksdorfii, its structure-activity correlation with related coumarins, and synergistic effects with anti-AIDS nucleosides. Bioorg. Med. Chem., 1994, 2, 1051-1056.
140. Huang, L.; Yuan, X.; Yu, D.; Lee, K.H.; Chen, C.H. Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives. Virology, 2005, 332, 623-628.
141. Ng, T.B.; Ling, J.M.; Wang, Z.T.; Cai, J.N.; Xu, G.J. Examination of coumarins, flavonoids and polysaccharopeptide for antibacterial activity. Gen. Pharmacol., 1996, 27, 1237-1240.
142. Kalkhambkar, R.G.; Kulkarni, G.M.; Kamanavalli, CM.; Premkumar, N; Asdaq, S.M.; Sun, CM. Synthesis and biological activities of some new fluorinated coumarins and 1 -aza coumarins. Eur. J. Med. Chem., 2008, 43, 2178-2188.
143. Tada, Y.; Shikishima, Y.; Takaishi, Y.; Shibata, H.; Higuti, T.; Honda, G.; Ito, M.; Takeda, Y.; Kodzhimatov, O.K.; Ashurmetov, O.; Ohmoto, Y. Coumarins and y-pyrone derivatives from Prangos pabularia: antibacterial activity and inhibition of cytokine release. Phytochemistry, 2002, 59, 649-654.
144. Roussaki, M.; Kontogiorgis, C.A.; Hadjipavlou-Litina, D.; Hamilakis, S.; Detsi, A. A novel synthesis of 3-aryl coumarins and evaluation of their antioxidant and lipoxygenase inhibitory activity. Bioorg. Med. Chem. Lett., 2010, 20, 3889-3892.
145. Wu, C.R.; Huang, MY.; Lin, Y.T.; Ju, H.Y.; Ching, H. Antioxidant properties of Cortex Fraxini and its simple coumarins. Food Chemistry, 2007, 104, 1464-1471.
146. Kancheva V.D.; Boranova, P.V.; Nechev, J.T.; Manolov, I.I. Structure-activity relationships of new 4-hydroxy bis-coumarins as radical scavengers and chain-breaking antioxidants. Biochimie, 2010, 92, 1138-1146.
147. Musa, M.A.; Khan, M.O.F; Cooperwood, J.S. Synthesis and antiproliferative activity of coumarin-estrogen conjugates against breast cancer cell lines. Lett. Drug Des. Discov., 2009, 6, 133-138.
148. Jacquot, Y.; Laios, I.; Cleeren, A.; Nonclercq, D.; Bermont, L.; Refouvelet, B.; Boubekeur, K; Xicluna, A.; Leclercq, G.; Laurent, G. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells. Bioorg. Med. Chem., 2007, 15, 2269-2282.
149. Reddy, N.S.; Gumireddy, K; Mallireddigari, M.R.; Cosenza, S.C.; Venkatapuram, P.; Bell, S.C; Reddy, E.P.; Reddy, M.V.R. Novel coumarin-3-(N-aryl)carboxamides arrest breast cancer cell growth by inhibiting ErbB-2 and ERK1. Bioorg. Med. Chem., 2005, 13, 3141-3147.
150. Starcevic, S.; Kocbek, P.; Hribar, G.; Rizner, T.L.; Gobec, S. Biochemical and biological evaluation of novel potent coumarin inhibitor of 17β3-HSD type 1. Chem. Biol. Interact., 2011, 191, 60-65.
151. Jaiyesimi, I.A.; Buzdar, A.U.; Decker, DA.; Hortobagyi, G.N. Use of tamoxifen for breast cancer: twenty-eight years later. J. Clin. Oncol, 1995, 13, 513-529.
152. Filardo, E.J.; Quinn, J.A.; Bland, K.I.; Frackelton A.R. Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol., 2000, 14, 1649-1660.
153. Fornander, T.; Rutqvist, L.E.; Cedermark, B.; Glas U; Mattsson A.; Silfverswärd, C; Skoog, L.; Somell, A.; Theve, T.; Wilking, N. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet., 1989, 21, 117-120.
154. Fisher, B.; Costantino, J.P.; Redmond, C.K.; Fisher, E.R.; Wickerham, D.L.; Cronin, W.M. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl. Cancer Inst., 1994, 86, 527-537.
155. Stanway, S.J.; Purohit, A.; Lawrence Woo, L.W.; Sufi, S.; Vigushin, D.; Ward, R.; Wilson, R.H.; Stanczyk, F.Z.; Dobbs, N; Kulinskaya, E.; Elliott, M.; Potter, B.V.L.; Reed, M. J.; Coombes, R.C. Phase I Study of STX 64 (667 Coumate) in Breast Cancer Patients: The First Study of a Steroid Sulfatase Inhibitor. Clin. Cancer Res., 2006, 12, 1585.
156. Dong, Y.; Shi, Q.; Nakagaw-Goto, K; Wu, P.C; Morris-Natschke, S.L.; Brossi, A.; Bastow, K.F.; Lang, J.Y.; Hung, M.C; Lee, K.H. Antitumor Agents 270. Novel Substituted 6-Phenyl-4H-furo[3,2-c]pyran-4-one Derivatives as Potent and Highly Selective Anti-Breast Cancer Agents. Bioorg. Med. Chem., 2010, 18, 803-808.
157. Wang, X.; Nakagawa-Goto, K; Bastow, K.F.; Don, M.J.; Lin, Y.L.; Wu, T.S.; Lee, K.H. Antitumor Agents. 254. Synthesis and Biological Evaluation of Novel Neo-tanshinlactone Analogues as Potent Anti-Breast Cancer Agents. J. Med. Chem., 2006, 49, 5631-5634.
158. Sashidhara, K.V.; Kumar, A.; kumar, M.; Sarkar, J.; Sinha, S. Synthesis and in vitro evaluation of novel coumarin-chalcone hybrids as potential Anticancer agents. Bioorg. Med. Chem. Lett., 2010, 20, 7205-7211.
159. Belluti, F.; Fontana, G.; Dal Bo, L.; Carenini, N; Giommarelli, C; Zunino, F. Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents. Bioorg. Med. Chem., 2010, 18, 3543-3550.
160. Bodine, P.V.; Harris, H.A.; Lyttle, C.R.; Komm, B.S. Estrogenic effects of 7alpha-methyl-17alpha-ethynylestradiol: a newly discovered tibolone metabolite. Steroids, 2002, 67, 681-686.
161. el Amouri, H.; Vessieres, A.; Vichard, D.; Top, S.; Gruselle, M.; Jaouen, G. Syntheses and affinities of novel organometallic-labeled estradiol derivatives: a structure-affinity relationship. J. Med. Chem., 1992, 35, 3130-3135.
162. Khan, E.H.; Ali, H.; Tian, H.; Rousseau J.; Tessier G.; Shafiullah van Lier J.E. Synthesis and biological activities of phthalocyanine-estradiol conjugates. Bioorg. Med. Chem. Lett., 2003, 13, 1287-1290.
163. Ahmed, N.; Dubuc, C.; Rousseau, J.; Benard, F.; van Lier, J.E. Synthesis, characterization, and estrogen receptor binding affinity of flavone-, indole-, and furan-estradiol conjugates. Bioorg. Med. Chem. Lett., 2007, 17, 3212-3216.
164. Musa, M.A.; Khan, M.O.F.; Cooperwood, J.S. Synthesis and antiproliferative activity of coumarin-estrogen conjugates against breast cancer cell lines. Lett. Drug Des. Discov., 2009, 6, 133-138.
165. Allen, D.D.; Smith, Q.R. Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique. J. Neurochem., 2001, 76, 1032-1041.
166. Saville, M.W.; Lietzau, J.; Pluda, J.M.; Feuerstein, I.; Odom, J.; Wilson, W.H.; Humphrey, R.W.; Feigal, E.; Steinberg, S.M.; Broder, S. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet, 1995, 346, 26-28.
167. Singla, A.K.; Garg, A.; Agarwal, D. Paclitaxel and its formulations. Int. J. Pharm., 2002, 235, 179-192.
168. Ozcelik, B.; Turkyilmaz, C.; Ozgun, M.T.; Srein, I.S.; Batukan, C.; Ozdamar, S.; Ozturk, A. Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist. Fertil. Steril., 2010, 93, 1609-1614.
169. Noguchi, M.; Skwarczynski, M.; Prakash, H.; Hirota, S.; Kimura, T.; Hayashi, Y.; Kiso, Y. Development of novel water-soluble photocleavable protective group and its application for design of photo responsive paclitaxel prodrugs. Bioorg. Med. Chem., 2008, 16, 5389-5397.
170. Brush, C.K. Fluorescein Labelled Phosphoramidites. US Patent 5,583,236.
171. Eldaw, A.; Khalfan, H.A. Aminomethyl coumarin acetic acid and fluorescein isothiocyanate in detection of leishmanial antibodies: a comparative study. Trans. R. Soc. Trop. Med. Hyg., 1988, 82, 561-562.
172. Thevenin, B.J.; Shahrokh, Z.; Willard, R.L.; Fujimoto, E.K.; Kang, J.J.; Ikemoto, N.; Shohet, S.B. A novel photoactivatable cross-linker for the functionally-directed region-specific fluorescent labeling of proteins. Eur. J. Biochem., 1992, 206, 471-477.
173. Baburaj, K.; Azam, N.; Udgaonkar, D.; Durani, S. HOCGO and DMACGO. Two coumarin derived alpha-dicarbonyls suitable as pH and polarity sensitive fluorescent reporters for proteins that can be targeted at reactive arginines. Biochim. Biophys. Acta., 1994, 1199, 253-265.
174. Stratford, M.R.; Dennis, M.F. Measurement of incorporation of bromodeoxyuridine into DNA by high performance liquid chromatography using a novel fluorescent labelling technique. Int. J. Radiat. Oncol. Biol. Phys., 1992, 22, 485-487.
175. Wells, G.; Suggeitt, M.; Coffils, M.; Baig, M.A.; Howard, P.W.; Loadman, P.M.; Hartley, J.A.; Jenkinsd, T.C.; Thurston, D.E. Fluorescent 7-diethylaminocoumarin pyrrolobenzodiazepine conjugates: Synthesis, DNA interaction, cytotoxicity and differential cellular localization. Bioorg. Med. Chem. Lett., 2008, 18, 2147-2151.
176. Koufaki, M.; Calogeropoulou, T.; Rekka, E.; Chryselis, M.; Papazafiri, P.; Gaitanakic, C.; Makriyannis, A. Bifunctional Agents for Reperfusion Arrhythmias: Novel Hybrid Vitamin E/Class I Antiarrhythmics. Bioorg. Med. Chem., 2003, 11, 5209-5219.
177. Choo, Q.L.; Kuo, G.; Weiner, A.J.; Overby, L.R.; Bradley, D.W.; Houghton, M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 1989, 244, 359-362.
178. Wasley, A.; Alter, M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin. Liver Dis., 2000, 20, 1-16.
179. De Francesco, R.; Tomei, L.; Altamura, S.; Summa, V.; Migliaccio, G. Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res., 2003, 58, 1-16.
180. Beaulieu, P.L.; Fazal, G.; Gillard, J.; Kukolj, G.; Austel, V. Viral polymerase inhibitors. Int. Patent Appl. WO 02/04425. Boehringer Ingelheim (Canada) Ltd. 2002.
181. Hashimoto, H.; Mizutani, K.; Yoshida, A. Preparation of heterocyclic compounds as remedies for hepatitis C. Int. Patent Appl. WO 01/47883. Japan Tobacco Inc. 2001.
182. Dhanak, D.; Kaura, A.; Shaw, A. Novel anti-infectives. Int. Patent Appl. WO 01/85172. Smithkline Beechham Corporation, Int. 2001.
183. Hwu, J.R.; Singha, R.; Hong, S.C.; Chang, Y.H.; Das, A.R.; Vliegen, I.; De Clercq, E; Neyts, J. Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents. Antiviral Res., 2008, 77, 157-162.
184. Morton, J.R.; Negri, F.; Preston, K.F. ChemInform Abstract: Addition of Free Radicals to C60. ChemInform, 1998, 29.
185. Bensasson, R.V.; Brettreich, M.; Frederiksen, J.; Göttinger, H.; Hirsch, A.; Land, E.J.; Leach, S.; McGarvey, D.J.; Schonberger, H. Reactions of e(-) (aq), CO(2)(*)(-), HO(*), O(2)(*)(-) and O(2)((1)delta(g)) with a dendro [60]fullerene and C(60)[C(COOH)(2)](n) (n = 2-6). Free Radic. Biol. Med., 2000, 29, 26-33.
186. Wang, I.C.; Tai, L.A.; Lee, D.D.; Kanakamma, P.P.; Shen, C.K.; Luh, T.Y.; Cheng, H.C.; Hwang, K.C. C60 and Water-Soluble Fullerene Derivatives as Antioxidants Against Radical-Initiated Lipid Peroxidation. J. Med. Chem., 1999, 42, 4614-4620.
187. Hsu, H.C.; Chiang, L.Y.; Chen, W.J.; Lee, Y.T. Water-Soluble Hexasulfobutyl Fullerene Inhibits Plasma Lipid Peroxidation by Direct Association with Lipoproteins. J. Cardiovas. Pharmacol., 2000, 36, 423-427.
188. Dugan, L.L.; Turetsky, D.M.; Du, C; Lobner, D.; Wheeler, M.; Almli, C.R.; Shen, C.K; Luh T.Y.; Choi D.W., Lin T.S. Carboxyfullerenes as neuroprotective agents. Proc. Natl. Acad. Sci. USA, Neurobiology, 1997, 94, 9434-9439.
189. Dugan, L.L.; Lovett, E.G.; Quick, K.L.; Lotharius, J.; Lin, T.T.; O'Malley, K.L. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat. Disord., 2001, 7, 243-246.
190. De La Torre, M.D.L.; Rodrigues, A.G.P.; Augusto C. Tome, A.C.; Silva, A.M.S.; Cavaleiro, J.A.S. Fullerene-flavonoid dyads. Tetrahedron, 2004, 60, 3581-3592.
191. De La Torre, M.D.L.; Tome, A.C.; Silva, A.M.S.; Cavaleiro, J.A.S. Synthesis of fullerene-quercetin dyads. Tetrahedron Lett., 2002, 43, 4617-4620.
192. Enes, R.F.; Farinha, A.S.F.; Tome, A.C.; Cavaleiro, J.A.S.; Amorati, R.; Petrucci, S.; Pedulli, G.F. Synthesis and antioxidant activity of fullerene-flavonoid conjugates. Tetrahedron, 2009, 65, 253-262.
193. Fang, L.; Kraus, B.; Lehmann, J.; Heilmann, J.; Zhang, Y.; Decker, M. Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates. Bioorg. Med. Chem. Lett., 2008, 18, 2905-2909.
194. P. Ischemic Cell Death in Brain Neurons. Physiol. Rev., 1999, 79, 1431-1568.
195. Croall, D.E.; DeMartino, G.N. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol. Rev., 1991, 71, 813-847.
196. Goll, D.E.; Thompson, V.F.; Li, H.; Wei, W.; Cong, J. The calpain system. Physiol. Rev., 2003, 83, 731-801.
197. Markgraf, C.G.; Velayo, N.L.; Johnson, M.P.; McCarty, D.R.; Medhi, S.; Koehl, J.R.; Chmielwski, P.A.; Linnik, M.D. Six-Hour Window of Opportunity for Calpain Inhibition in Focal Cerebral Ischemia in Rats. Stroke, 1998, 29, 152-158.
198. Boland, B.; Campbell, V.C. P-Amyloid (1-40) - induced apoptosis of cultured cortical neurones involves calpain-mediated cleavage of poly-ADP-ribose polymerase. Neurobiol. Aging, 2003, 23, 179-186.
199. Lee, K.S.; Seo, S.H.; Lee, Y.H.; Kim, H.D.; Son, M.H.; Chung, BY.; Lee, J.Y.; Jin, C; Lee, Y.S. Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors. Bioorg. Med. Chem. Lett., 2005, 15, 2857-2860.
200. Yoo, Y.J.; Nam, D.H.; Jung, S.Y.; Jang, J.W.; Kim, H.Ja.; Jin, C; Pae, AN.; Lee, Y.S. Synthesis of cinnamoyl ketoamides as hybrid structures of antioxidants and calpain inhibitors. Bioorg. Med. Chem. Lett., 2011, 21, 2850-2854.
201. Garcia, G.; Rodriguez-Puyol, M.; Alajarin, R.; Serrano, I.; Sanchez-Alonso, P.; Griera, M.; Vaquero, J.J.; Rodríguez-Puyol, D; Alvarez-Builla, J.; Diez-Marques, M.L. Losartan-Antioxidant Hybrids: Novel Molecules for the Prevention of Hypertension-Induced Cardiovascular Damage. J. Med. Chem., 2009, 52, 7220-7227.
202. Nomura, E.; Hosoda, A.; Morishita, H.; Murakami, A.; Koshimizu, K; Ohigashi, H.; Taniguchi, H. Synthesis of Novel Polyphenols Consisted of Ferulic and Gallic Acids, and Their Inhibitory Effects on Phorbol Ester-Induced Epstein-Barr Virus Activation and Superoxide Generation. Bioorg. Med. Chem., 2002, 10, 1069-1075.
203. Takeda Y.; Tanigawa, N.; Sunghwa, F.; Ninomiya, M.; Hagiwara, M.; Matsushita, K; Koketsu, M. Morroniside cinnamic acid conjugates as an anti-inflammatory agent. Bioorg. Med. Chem. Lett., 2010, 20, 4855-4857.
204. Jahan, M.S.; McKinny, K.S. Radiation-sterilization and subsequent oxidation of medical grade polyethylene: An ESR study. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, 1999, 151, 207-212.
205. Ortiz, C.; Vazquez, B.; San Roman, J. Hydrophilic acrylic biomaterials derived from vitamin E with antioxidant properties. J. Biomed. Mater. Res., 1999, 45, 184-191.
206. Atkinson, D.; Lehrle, R. A model polymer-bound antioxidant system for lubricants. Eur. Poly. J., 1992, 28, 1569-1575.
207. Al-Malaika, S.; Suharty, N. Reactive processing of polymers: mechanisms of grafting reactions of functional antioxidants on polyolefins in the presence of a coagent. Polym. Degrad. Stab., 1995, 49, 77-89.
208. Youk, H.J.; Lee, E.; Choi, M.K.; Lee, Y.J.; Chung, J.H.; Kim, S.H.; Lee, C.H.; Lim, S.J. Enhanced anticancer efficacy of a-tocopheryl succinate by conjugation with polyethylene glycol. J. Control. Release, 2005, 107, 43-52.
209. Spizzirri, U.G.; Iemma, F.; Puoci, F.; Cirillo, G.; Curcio, M.; Parisi, O.I.; Picci, N. Synthesis of antioxidant polymers by grafting of gallic acid and catechin on gelatin. Biomacromolecules, 2009, 10, 1923-1930.
210. Curcio, M.; Cirillo, G.; Parisi, O.I.; Iemma, F.; Spizzirri, U.G.; Altimari, I.; Picci, N.; Puoci, F. Poly(2-hydroxyethyl methacrylate)-quercetin conjugate as biomaterial in ophthalmology: An "ab initio" study. J. Funct. Biomaterials, 2011, 2, 1-17.
211. Spizzirri, U.G.; Parisi, O.I.; Iemma, F.; Cirillo, G.; Puoci, F.; Curcio, M.; Picci, N. Antioxidant-polysaccharide conjugates for food application by eco-friendly grafting procedure. Carbohydrate Polymers, 2010, 79, 333-340.
212. Yu, S.H.; Mi, F.L.; Pang, J.C.; Jiang, S.C.; Kuo, T.H.; Wu, S.J.; Shyu, S.S. Preparation and characterization of radical and pH-responsive chitosan-gallic acid conjugate drug carriers. Carbohydrate Polymers, 2011, 84, 784-802.